Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 8.72 CHF 3.81% Market Closed
Market Cap: 359.8m CHF
Have any thoughts about
Medmix Ltd?
Write Note
MEDX
/
Cash Flow Statement
/
Cash Interest Paid

Medmix Ltd
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medmix Ltd
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Medmix Ltd
SIX:MEDX
Cash Interest Paid
CHf6.3m
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Metall Zug AG
SIX:METN
Cash Interest Paid
CHf748k
CAGR 3-Years
70%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Sonova Holding AG
SIX:SOON
Cash Interest Paid
CHf25.3m
CAGR 3-Years
13%
CAGR 5-Years
54%
CAGR 10-Years
17%
Medacta Group SA
SIX:MOVE
Cash Interest Paid
€5.8m
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Straumann Holding AG
SIX:STMN
Cash Interest Paid
CHf15.7m
CAGR 3-Years
3%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Medmix Ltd
Glance View

Market Cap
355.7m CHF
Industry
Health Care

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

MEDX Intrinsic Value
23.96 CHF
Undervaluation 64%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Medmix Ltd's Cash Interest Paid?
Cash Interest Paid
6.3m CHF

Based on the financial report for Dec 31, 2023, Medmix Ltd's Cash Interest Paid amounts to 6.3m CHF.

What is Medmix Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
-3%

Over the last year, the Cash Interest Paid growth was -3%. The average annual Cash Interest Paid growth rates for Medmix Ltd have been -6% over the past three years , -3% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.